Ittehad Chemicals FY26: Q4 Growth, Debt and Margins

Verdict: Ittehad Chemicals finished FY2026 with its strongest sales quarter of the year and materially higher annual earnings, but the quality of that growth is mixed. Consolidated revenue rose 23.2% to Rs34.31 billion and profit after tax increased 16.4% to Rs1.50 billion. Derived Q4 revenue was about Rs10.18 billion, up 35.5% year on year, while Q4 PAT rose 23.2%. The problem is that costs grew faster than sales over the full year: gross margin fell to 15.4% from 17.9%, and operating margin also compressed. At the same time, a large expansion programme pushed year-end interest-bearing debt close to Rs8.74 billion and working capital absorbed substantial cash. The next result therefore needs to show that the new capacity and energy projects can convert rapid sales growth into better margins and cash generation rather than simply a larger balance sheet.

Results at a glance

Company Name: Ittehad Chemicals Ltd
Ticker: ICL
Reporting period: year ended June 30, 2026, with Q4 figures in this article derived from the official full-year result less the official nine-month figures.
Reporting basis: consolidated financial statements in Pakistani rupees, with FY2025 comparatives. The September 15 board-meeting notice states that the board would consider standalone and consolidated audited annual accounts; the September 22 PSX result announcement followed that meeting and includes summarized standalone and consolidated statements. The result attachment itself does not reproduce the external auditor's report.
FY2026 revenue was Rs34.31 billion, up 23.2% from Rs27.86 billion.
Gross profit rose 6.0% to Rs5.29 billion, but gross margin fell to 15.4% from 17.9%.
Operating profit increased 7.6% to Rs3.07 billion, while operating margin slipped to 8.9% from 10.2%.
Profit after tax rose 16.4% to Rs1.50 billion and consolidated EPS increased to Rs15.01 from Rs12.90.
Derived Q4 revenue was about Rs10.18 billion, up 35.5% year on year; Q4 PAT was about Rs445.9 million, up 23.2%.
The board recommended a final cash dividend of Rs3.00 per share, in addition to Rs1.00 per share of interim cash dividend already paid.

AlphaGen model outputs

The following are AlphaGen model outputs, not company-reported figures:

Alpha QoQ Score: 85.26
TTM Performance Score: 78.43
3Y Business Perf Score: 66.95
Sector Leadership Score: 38.2556

What improved

The most encouraging feature of the result is the acceleration into the June quarter. Subtracting the official 9MFY26 figures from the audited-year result gives Q4 revenue of about Rs10.18 billion versus Rs7.52 billion in Q4 FY2025. Gross profit rose about 33.2% to Rs1.67 billion, operating profit about 18.6% to Rs913.5 million and PAT about 23.2% to Rs445.9 million. That makes Q4 the clearest evidence that ICL entered year-end with stronger commercial momentum than the full-year averages alone suggest.

The public disclosures provide some support for why sales expanded, but they do not provide a complete Q4 volume-price bridge. In its June corporate briefing, management said 9MFY26 sales growth reflected higher quantities sold together with the pass-through of higher raw-material and energy costs into selling prices. VIS also reported higher production and utilization in core products including caustic soda liquid, caustic soda flakes, hydrochloric acid and sodium hypochlorite, alongside sustained local demand. It is therefore reasonable to infer that both volume and pricing contributed to FY2026 growth. The exact Q4 split is not disclosed and should not be invented.

Q4 gross margin was approximately 16.4%, only modestly below the roughly 16.7% derived for Q4 FY2025 and noticeably better than the 15.0% reported for 9MFY26. That suggests the gross-margin squeeze eased late in the year even though it did not disappear. Finance cost also improved: full-year finance cost fell 13.4% to Rs549.0 million, and derived Q4 finance cost fell about 25.8% year on year. Lower benchmark interest rates through much of the year are consistent with that direction, although the filing does not provide a detailed rate-versus-volume financing bridge.

What weakened / needs attention

The central weakness is margin dilution. Cost of sales climbed 26.9%, faster than the 23.2% rise in revenue, leaving gross profit up only 6.0%. Full-year gross margin therefore fell by about 249 basis points to 15.4%. This is not a new issue that appeared only at year-end: management's 9M briefing explicitly attributed higher cost of sales to higher raw-material and energy costs and said selling prices had absorbed some of those pressures. VIS similarly described energy as a key industry cost and noted that ICL's gross margin had already declined in 9MFY26.

Operating expenses added another layer of pressure. Selling and distribution expense was slightly lower, but general and administrative expense rose 24.8% and other operating expense rose 36.4%. Operating profit still increased, but much more slowly than revenue, so operating margin fell by roughly 129 basis points. Q4 also remained below the prior-year operating-margin level despite the strong top-line growth. This matters because a chemical producer with energy-intensive processes needs high utilization and disciplined conversion of pricing into gross profit; sales growth by itself is not enough.

Below the operating line, the result was cleaner. Finance cost fell, the group recorded only a Rs3 million share of loss from an associate, and profit before tax increased 13.9%. Net tax expense rose to Rs1.01 billion from Rs917.5 million, but the effective tax burden eased slightly, allowing PAT to rise 16.4%. The bottom-line improvement therefore came from higher operating profit plus lower finance cost rather than a large exceptional gain.

Balance sheet expansion is now the bigger story

The FY2026 balance sheet expanded sharply. Consolidated assets rose to Rs26.71 billion from Rs20.16 billion. Property, plant and equipment increased to Rs14.46 billion from Rs10.37 billion, while the cash-flow statement shows Rs4.59 billion of additions to capital work in progress during the year. That scale of capital deployment is consistent with ICL's strategic project pipeline, which includes the biomass power project, a new caustic soda flaker plant and a calcium chloride plant.

The financing consequence is visible. Long-term financing rose to Rs5.19 billion from just Rs488 million, while the current portion of long-term liabilities increased to Rs983 million. Short-term borrowings fell to Rs2.57 billion from Rs4.54 billion, so the debt mix shifted materially toward longer-tenor funding. Even after the short-term reduction, total interest-bearing borrowings ended near Rs8.74 billion versus roughly Rs5.47 billion a year earlier, an increase of about 60%.

That increase does not automatically mean liquidity deteriorated. The current ratio improved to about 1.32x from 1.05x because current assets grew faster than current liabilities. But the composition of those current assets deserves attention: inventory increased to Rs3.75 billion from Rs2.68 billion and trade receivables rose to Rs4.67 billion from Rs3.28 billion. More capital is tied up in producing and collecting sales.

Cash conversion shows the same tension. Before working-capital movements, operating cash flow was Rs3.99 billion, up from Rs3.66 billion. But increases in inventories, receivables, stores and other current assets absorbed about Rs3.22 billion. Higher trade and other payables plus contract liabilities provided roughly Rs1.96 billion of offset. After taxes, gratuity and finance costs, net operating cash generation was Rs951 million, slightly below Rs987 million a year earlier despite higher earnings.

Investment cash outflow was Rs4.02 billion. The largest item was the Rs4.59 billion addition to capital work in progress, partly offset by Rs627 million of proceeds from the sale of investment property. Financing activities therefore had to supply Rs3.14 billion of net cash, led by Rs5.23 billion of net long-term financing. The property-sale proceeds are useful cash, but they are not a recurring operating source and should not be confused with stronger cash conversion from the chemicals business.

Strategic projects: the payoff is still ahead

ICL's investment case from an operating perspective is increasingly tied to whether the current projects deliver the promised economics. In its June corporate briefing, the company described a 37.2 MW biomass co-generation project, a 16,500 MT per annum caustic soda flaker plant and a calcium chloride plant among its strategic initiatives. It also described a phased efficiency upgrade to its existing gas-fired power plant that is intended to raise capacity and fuel efficiency. The same briefing still presented the biomass, flaker and calcium chloride projects as upcoming strategic projects.

That distinction matters. The FY2026 result contains substantial capital work in progress, but the final result announcement does not provide evidence that the major projects had all reached stable commercial operation by June 30. Expected energy savings, higher-value product mix and additional capacity should therefore be treated as future operating tests, not as earnings already embedded in FY2026.

VIS had highlighted the same trade-off in May: the biomass project and flaker expansion could lower energy costs and improve product mix, but project financing was expected to raise debt and pressure capitalization indicators before the benefits fully arrive. The year-end balance sheet now shows that debt build-up clearly. The next few quarters should reveal whether the project economics start catching up with the financing burden.

Sector context: company growth outpaced a mixed chemicals backdrop

Pakistan's overall large-scale manufacturing output rose 4.98% in FY2026, according to PBS. The chemical sector picture was weaker earlier in the year: the Pakistan Economic Survey reported a 1.4% contraction in chemicals during July-March FY2026, with chemical products down 2.2%. Against that backdrop, ICL's 23% revenue growth and management's reported increase in quantities sold indicate company-level momentum stronger than the broad sector average, though revenue growth also includes price pass-through and cannot be compared directly with an output index.

The sector remains energy-intensive, which makes ICL's power strategy economically important. VIS notes that chlor-alkali production requires high utilization for cost efficiency and that energy costs remain a major industry pressure. This helps explain why management is simultaneously pursuing higher-value caustic-soda flakes and captive biomass power: one initiative targets mix, while the other targets a structural cost line.

Working capital remains a live issue after year-end as well. On July 21, ICL disclosed that it had issued Rs1.5 billion of rated, unsecured, privately placed short-term Sukuk with a tenure of up to six months specifically for working-capital requirements. That post-period financing does not change the June 30 balance sheet, but it reinforces the need to watch how quickly receivables and inventory convert into cash as sales scale.

Recurring versus non-recurring drivers

Recurring or potentially recurring: sales volumes, domestic demand, product pricing and mix, raw-material and energy costs, distribution efficiency, finance costs and working-capital conversion.
Structural but execution-dependent: the biomass power, flaker and calcium chloride projects. If commissioned successfully, these could alter energy economics, capacity and product mix, but their benefits should be judged from reported results rather than project targets.
Non-recurring or episodic cash support: the Rs627 million sale of investment property helped fund the investment programme but should not be treated as recurring operating cash generation.
Timing-sensitive: the sharp increase in long-term debt reflects a capex cycle whose financing cost may arrive before the full operating benefit. The July short-term Sukuk adds another working-capital funding layer after year-end.

Dividend and capital allocation

The board recommended a Rs3.00-per-share final cash dividend in addition to the Rs1.00 interim dividend already paid. If approved through the normal shareholder process, the full-year distribution would total Rs4.00 per share. At the same meeting, the board also recommended increasing ICL's long-term investment in associated company Biostacks (Private) Limited up to Rs2 billion. The result announcement provides no detailed return profile for that proposed investment, so the relevant next-cycle question is how much cash is actually deployed, on what timeline, and how it interacts with the already heavy project and working-capital commitments.

What to monitor next

First, watch gross margin rather than sales alone. Q4 sales growth was excellent and the quarter's gross margin stabilized relative to the weak 9M level, but the full-year margin still fell materially. A convincing improvement would require input-cost pass-through and energy savings to show up in gross profit, not just revenue.

Second, track project commissioning and utilization. The biomass plant and flaker project are strategically important because they target ICL's two most visible economic constraints: energy cost and product value addition. The next disclosures should show actual operating status, production contribution and cost impact.

Third, monitor debt and finance costs together. Year-end borrowings rose sharply even as FY2026 finance cost fell. With SBP's policy rate at 11.5% in June 2026 and a new short-term Sukuk issued after year-end, the cost of the enlarged funding base could become more visible in the next cycle.

Fourth, focus on cash conversion. Inventory and receivables grew faster than sales, while operating cash flow did not keep pace with earnings. The strongest confirmation of sustainable growth would be a reversal of that working-capital absorption without rebuilding short-term bank debt.

Finally, follow capital allocation. The final dividend, the proposed Biostacks investment and the existing expansion programme all compete for cash. FY2026 proved that ICL can grow revenue and earnings; FY2027 needs to prove that the larger asset and debt base can earn an adequate operating return and generate cash consistently.

Sources

Pakistan Stock Exchange — ICL company page and announcement record confirming the September 22, 2026 financial result for the year ended June 30, 2026. Open source.
Ittehad Chemicals Limited / PSX — official FY2026 financial-results filing containing the board decision, dividend, capital-allocation disclosure, and summarized standalone and consolidated financial statements. Open source.
Ittehad Chemicals Limited / PSX — September 15, 2026 board-meeting notice confirming consideration of standalone and consolidated audited annual accounts for FY2026. Open source.
Ittehad Chemicals Limited — revised June 2026 corporate briefing presentation, used for 9MFY26 drivers, project pipeline, operating context and management's raw-material/energy-cost commentary. Open source.
Ittehad Chemicals Limited / PSX — July 21, 2026 Sukuk disclosure confirming the Rs1.5 billion short-term issue for working-capital requirements. Open source.
Pakistan Bureau of Statistics — June 2026 provisional Quantum Index of Large Scale Manufacturing, used for full-year manufacturing context. Open source.
Finance Division — Pakistan Economic Survey 2025-26, used for the July-March chemicals and chemical-products operating backdrop. Open source.
State Bank of Pakistan — June 15, 2026 Monetary Policy Statement, used for the 11.5% policy-rate context relevant to incremental financing. Open source.
VIS Credit Rating Company — May 2026 ICL rating report, used as an independent cross-check on product utilization, energy intensity, project financing and liquidity risks. Open source.